2008
DOI: 10.1016/j.thromres.2008.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Spectrofluorimetric assessment of plasma dipyridamole stability: Sample storage for multicenter clinical trials?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
3
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…Indeed, assessing drug concentrations serially, at different time points in just one patient undergoing treatment with ERD takes about 4 hours (h) of preparation and fluorometry time representing the major challenge preventing this informative technique to spread beyond high-profile academic facilities. However, maintaining durability of plasma dipyridamole concentration over time, and potential storage of the drug within lipophilic cell membranes may represent an attractive alternative to the pharmacokinetics of currently available antithrombotics (14). Considering alarmingly high non-compliance rates for antithrombotics in general (15), and ERD in particular (16) missing even one daily dose may represent a serious challenge for maintaining efficacy.…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, assessing drug concentrations serially, at different time points in just one patient undergoing treatment with ERD takes about 4 hours (h) of preparation and fluorometry time representing the major challenge preventing this informative technique to spread beyond high-profile academic facilities. However, maintaining durability of plasma dipyridamole concentration over time, and potential storage of the drug within lipophilic cell membranes may represent an attractive alternative to the pharmacokinetics of currently available antithrombotics (14). Considering alarmingly high non-compliance rates for antithrombotics in general (15), and ERD in particular (16) missing even one daily dose may represent a serious challenge for maintaining efficacy.…”
Section: Introductionmentioning
confidence: 99%
“…Spectrophotometry and conductometry have low sensitivity and selectivity. On the other hand, methods, such as phosphorimetry [13], chemiluminescence [14], and fluorimetry [15], have shown the achievement of lower limits of detection and higher selectivity and sensitivity compared to other traditional detection methods of DIP.…”
Section: Introductionmentioning
confidence: 99%
“…In order to improve their performance, athletes have sometimes fraudulently consumed DIP, but the uncontrolled administration of this drug can have serious side effects [13]. DIP's effects in the body last a long time and its concentration in blood and urine is usually very low [14,15], but DIP plasma content remains unchanged over 2 weeks of storage [16]. Thus, the development of sensitive and selective methods for DIP assay in pharmaceutical and biological samples is required.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the development of sensitive and selective methods for DIP assay in pharmaceutical and biological samples is required. As DIP ( Figure 1) contains a stable heteroaromatic double * Correspondence: i _ g _ david@yahoo.com central system responsible for its absorption and fluorescence characteristics [17], several analytical methods exploiting these properties [18][19][20][21], as well as other luminescence-based methods [13][14][15][16][17][18][19][20][21][22], have been developed for its quantification. On the other hand, several chromatographic methods with either spectrometric [23][24][25] or electrochemical [26] detection were reported for DIP analysis.…”
Section: Introductionmentioning
confidence: 99%